Top 5 Must-Follow Earnings for Monday

NEW YORK (TheStreet) -- Another week into earnings season and Wall Street is still moving at full speed. Here is what to watch on Monday.

Vivus (VVUS)

Who They Are:Vivus is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. Vivus trades an average of 14.1 million shares per day with a marketcap of $2.2 billion.

VVUS Chart VVUS data by YCharts

Vivus is forecast to record shallow second-quarter earnings after the market closes July 30. The consensus estimate is currently a loss of 23 cents a share, another drop of three cents from a loss of 20 cents during the equivalent quarter last year.

Analyst opinion is mixed with this company. Most of the analysts surveyed don't believe a buy or a sell is currently warranted. Right now, Vivus has five buy recommendations out of 11 analysts covering the company, six holds, and no analysts recommend selling.

Four out of 11 analysts now rate Vivus a strong buy down from five analysts a month ago. Compared to three months ago, fewer analysts are rating this company as a strong buy. The stock has appreciated 180% in the last year, and the average analyst target price for Vivus is $38.29.

It's not a typo, Vivus really is up 180% and it was on my radar a lot.

The last date Vivus released earnings was May 7, and the closing price before earnings was $23.58. Based on Tuesday's closing price of $23, shares are down 2.5%.

The bottom line has falling earnings year-over-year with a loss of $46.14 million last fiscal year compared to an even bigger loss of $66.07 million in the previous year.

With 15% short interest, investors better know what they are doing before picking this one up -- 15% is the sweet spot for short interest as a bearish indicator. I like what they do as a company, but I would avoid the stock as an investment at this level. The earnings release may not have much of an impact either way because of the binary reaction pharmaceuticals have to trial results.

STX Chart STX data by YCharts

Seagate Technology (STX)

Who They Are:Seagate Technology is the worldwide leader in the design, manufacture and marketing of hard disc drives. Seagate Technology trades an average of 8 million shares per day with a marketcap of $11.3 billion.

Fourth-quarter earnings are highly anticipated by hopeful investors expecting an earnings growth report after the market closes on July 30. The analysts' mean appraisal is presently $2.51 a share, a gain of $2.23 (88.8%) from 28 cents during the corresponding quarter last year.

Analysts are more or less side-stepping this one like a politician dancing the Washington two-step. A hold can mean everything from "I want to rate it a sale, but that would not be good for business", to "I have no clue." Ten out of 19 rate this a hold. Seven recommend this as a buy and two recommend selling.

Seven out of 19 analysts now rate STX a strong buy down from nine analysts a month ago. Compared to three months ago, fewer analysts are rating this company as a strong buy. The stock has appreciated 81.2% in the last year, and the average analyst target price for STX is $29.15.

In the previous STX's earnings release April 17, the closing price before earnings was $27.89. In comparison to a recent price of $26.47, shares are down 2%.

The company has falling revenue year-over-year of $10.97 billion last fiscal year compared to $11.40 billion in the previous year. The bottom line has falling earnings year-over-year of $511 million last fiscal year compared to $1.61 billion in the previous year.

Seagate continues to move higher following a bullish trend with moving averages pointing higher as well. The price-to-earnings multiple suggests Seagate is a value buy as long as they don't hit any speed bumps.

I believe Seagate will come in very close to the estimate, but even a small miss should not hit the share price hard.

APC Chart APC data by YCharts

Anadarko Petroleum (APC)

Who They Are:Anadarko Petroleum Corporation is one of the world's largest independent oil and gas exploration and production companies. Anadarko Petroleum trades an average of 6.8 million shares per day with a marketcap of $35.1 billion.

APC is forecast to report weak second-quarter earnings after the market closes on July 30. The consensus estimate is currently 78 cents a share, slumping 36 cents (31.6%) from $1.14 during the same period last year.

Twenty-one out of 25 analysts (over 70%) rate APC a buy or strong buy. The company has four analysts rating it a hold, and not a sell rating to be found.

Nineteen out of 25 analysts now rate APC a strong buy up from 18 analysts a month ago. Compared to three months ago, even more analysts are rating this company as a strong buy. Shareholders have not been rewarded for their patience, shares have fallen 14.9% in the last year. The average analyst target price for APC is $97.64.

In the previous APC's earnings release on April 30, the closing price before earnings was $73.21. In comparison to a recent price of $67.78, shares are down 7.2%.

For the same fiscal period year-over-year, revenue has declined to $13.97 billion last fiscal year compared to $10.98 billion in the previous year. The bottom line has falling earnings year-over-year with a loss of $2.65 billion last fiscal year compared to a profit of $761 million in the previous year.

The short interest is relatively low and a non-factor at 1.39%.

FST Chart FST data by YCharts

Forest Oil (FST)

Who They Are:Forest Oil is engaged in the acquisition, exploration, development, production and marketing of natural gas and crude oil in North America. Forest Oil trades an average of 6.6 million shares per day with a marketcap of $825 million.

Forest is forecast to report weak second-quarter earnings after the market closes on July 30. The consensus estimate is currently 6 cents a share, a slumping 30 cents (83.3%) from 36 cents during the same period last year.

Analyst opinion is mixed with this company. Most of the analysts surveyed don't believe a buy or a sell is currently warranted. Right now, Forest has six buy recommendations out of 16 analysts covering the company, along with nine holds, while one recommends selling.

Analysts have walked further away as the shares have moved lower. Five out of 16 analysts now rate Forest a strong buy down from nine analysts a month ago. Shareholders have not been rewarded for their patience, shares have fallen 73.5% in the last year, and the average analyst target price for Forest is $13.14.

April 30 was the last earnings release with a closing price of $13.32. Relative to a current price of $6.53, shares are down 49.8%.

For the same fiscal period year-over-year, revenue has declined slightly to $704.56 million last fiscal year compared to $708.68 million in the previous year. The bottom line has falling earnings year-over-year of $137.84 million last fiscal year compared to $227.52 million in the previous year.

The short interest is relatively high at 14% and could turn into the fuel for a short squeeze if Forest can deliver. It's hard to handicap this stock, and the best thing I know about it is I talked a friend out of it a while ago, saving him some money.

Forest missed earnings three in the last four quarters, the average miss was 6 cents, and the one surprise beat was for 0.05 cents (16.13%) per share.

MAS Chart MAS data by YCharts

Masco (MAS)

Who They Are:Masco is the country's leading manufacturer of home improvement and building products and trades an average of 5.5 million shares per day with a marketcap of $5 billion.

Book Value: $1.60
Float Short: 7.30%

MAS Earnings Per Share Chart MAS Earnings Per Share data by YCharts

Masco is anticipated to report good second-quarter earnings after the market closes on July 30. The consensus estimate is currently 11 cents a share, an improvement of 6 cents (54.5%) from 5 cents during the same period last year.

Analyst opinion is mixed with this company. Most of the analysts surveyed don't believe a buy or a sell should be made at this point. Right now, Masco has two buy recommendations out of 13 analysts covering the company, nine holds, and two recommend selling. The stock has appreciated 21.5 % in the last year, and the average analyst target price for Masco is $13.88.

In the previous earnings release on April 30, the closing price before earnings was $13.18. In comparison to a recent price of $13.63, shares are down 4.8%.

For the same fiscal period year-over-year, revenue has declined to $7.47 billion last fiscal year compared to $7.49 billion in the previous year. The bottom line has lower losses year-over-year of $578 million last fiscal year compared to a loss of $1.05 billion in the previous year.

The company's earnings before interest and taxes are rising with an EBIT year-over-year loss of $295 million for the last fiscal year vs. a loss of $463 million for the previous annual report.

At the time of publication, the author held no positions in any of the stocks mentioned.

This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.

More from Opinion

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Apple Buys Tesla? Amazon Buys Sears? 3 Dream Mergers That Just Make Sense

Apple Buys Tesla? Amazon Buys Sears? 3 Dream Mergers That Just Make Sense

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many

Amazon's Assault on Grocery Stores Will Have a Profound Impact on Many

It's Dumb to Think There Aren't Already Monopolies in Big Tech

It's Dumb to Think There Aren't Already Monopolies in Big Tech

Google's EU Battles Are Hardly a Reason to Panic

Google's EU Battles Are Hardly a Reason to Panic